<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33519812</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>MicroRNA-30a Modulates Type I Interferon Responses to Facilitate Coxsackievirus B3 Replication <i>Via</i> Targeting Tripartite Motif Protein 25.</ArticleTitle><Pagination><StartPage>603437</StartPage><MedlinePgn>603437</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">603437</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2020.603437</ELocationID><Abstract><AbstractText>Viral myocarditis is caused by a viral infection and characterized by the inflammation of the myocardium. Coxsackievirus B3 (CVB3) infection is one of the most common among the infections caused by this virus. The host's early innate immune response to CVB3 infection particularly depends on the functions of type I interferons (IFNs). In this study, we report that a host microRNA, miR-30a, was upregulated by CVB3 to facilitate its replication. We demonstrated that miR-30a was a potent negative regulator of IFN-I signaling by targeting tripartite motif protein 25 (TRIM25). In addition, we found that TRIM25 overexpression significantly suppressed CVB3 replication, whereas <i>TRIM25</i> knockdown increased viral titer and VP1 protein expression. MiR-30a inhibits the expression of TRIM25 and TRIM25-mediated retinoic acid-inducible gene (RIG)-I ubiquitination to suppress IFN-&#x3b2; activation and production, thereby resulting in the enhancement of CVB3 replication. These results indicate the proviral role of miR-30a in modulating CVB3 infection for the first time. This not only provides a new strategy followed by CVB3 in order to modulate IFN-I-mediated antiviral immune responses by engaging host miR-30a but also improves our understanding of its pathogenesis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Li, Xie, Li, Li, Shen, Gong and Zhang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Shanghai Children's Hospital, Shanghai Jiaotong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Yewei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Shanghai Children's Hospital, Shanghai Jiaotong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Liwei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Disease and Zoonose, Yangzhou University, Yangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaobing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Shanghai Children's Hospital, Shanghai Jiaotong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Shanghai Children's Hospital, Shanghai Jiaotong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Shanghai Children's Hospital, Shanghai Jiaotong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Rufang</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Shanghai Children's Hospital, Shanghai Jiaotong University, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C546086">MIRN30b microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011971">Receptors, Immunologic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000070584">Tripartite Motif Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000627674">VP1 protein, enterovirus B</NameOfSubstance></Chemical><Chemical><RegistryNumber>77238-31-4</RegistryNumber><NameOfSubstance UI="D016899">Interferon-beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="C084523">TRIM25 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C452820">RIGI protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D000071457">DEAD Box Protein 58</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071457" MajorTopicYN="N">DEAD Box Protein 58</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016899" MajorTopicYN="N">Interferon-beta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="N">Myocarditis</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032383" MajorTopicYN="N">Myocytes, Cardiac</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011971" MajorTopicYN="N">Receptors, Immunologic</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000070584" MajorTopicYN="N">Tripartite Motif Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="N">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054875" MajorTopicYN="N">Ubiquitination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CVB3</Keyword><Keyword MajorTopicYN="N">TRIM25</Keyword><Keyword MajorTopicYN="N">miR-30a</Keyword><Keyword MajorTopicYN="N">type I IFN responses</Keyword><Keyword MajorTopicYN="N">viral replication</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>1</Day><Hour>5</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33519812</ArticleId><ArticleId IdType="pmc">PMC7840606</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2020.603437</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2013) 34(33):2636&#x2013;48, 2648a-2648d. &#xa0;10.1093/eurheartj/eht210</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht210</ArticleId><ArticleId IdType="pubmed">23824828</ArticleId></ArticleIdList></Reference><Reference><Citation>Esfandiarei M, McManus BM. Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol (2008) 3:127&#x2013;55. &#xa0;10.1146/annurev.pathmechdis.3.121806.151534</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pathmechdis.3.121806.151534</ArticleId><ArticleId IdType="pubmed">18039131</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Stafford KA, Sung YK. Update on coxsackievirus B3 myocarditis. Curr Opin Rheumatol (2012) 24(4):401&#x2013;7. &#xa0;10.1097/BOR.0b013e328353372d</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0b013e328353372d</ArticleId><ArticleId IdType="pmc">PMC4536812</ArticleId><ArticleId IdType="pubmed">22488075</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation (2001) 104(9):1076&#x2013;82. &#xa0;10.1161/hc3401.095198</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hc3401.095198</ArticleId><ArticleId IdType="pubmed">11524405</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber SA, Gauntt CJ, Sakkinen P. Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity. Adv Virus Res (1998) 51:35&#x2013;80. &#xa0;10.1016/s0065-3527(08)60783-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0065-3527(08)60783-6</ArticleId><ArticleId IdType="pubmed">9891585</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack A, Kontorovich AR, Fuster V, Dec GW. Viral myocarditis&#x2013;diagnosis, treatment options, and current controversies. Nat Rev Cardiol (2015) 12(11):670&#x2013;80. &#xa0;10.1038/nrcardio.2015.108</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2015.108</ArticleId><ArticleId IdType="pubmed">26194549</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 116(2):281&#x2013;97. 10.1016/s0092-8674(04)00045-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(04)00045-5</ArticleId><ArticleId IdType="pubmed">14744438</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell (2009) 136(2):215&#x2013;33. &#xa0;10.1016/j.cell.2009.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.01.002</ArticleId><ArticleId IdType="pmc">PMC3794896</ArticleId><ArticleId IdType="pubmed">19167326</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottwein E, Cullen BR. Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe (2008) 3(6):375&#x2013;87. &#xa0;10.1016/j.chom.2008.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2008.05.002</ArticleId><ArticleId IdType="pmc">PMC3079432</ArticleId><ArticleId IdType="pubmed">18541214</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, et al. A cellular microRNA mediates antiviral defense in human cells. Science (2005) 308(5721):557&#x2013;60. &#xa0;10.1126/science.1108784</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1108784</ArticleId><ArticleId IdType="pubmed">15845854</ArticleId></ArticleIdList></Reference><Reference><Citation>Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K, et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science (2007) 315(5818):1579&#x2013;82. &#xa0;10.1126/science.1136319</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1136319</ArticleId><ArticleId IdType="pubmed">17322031</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathans R, Chu CY, Serquina AK, Lu CC, Cao H, Rana TM. Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol Cell (2009) 34(6):696&#x2013;709. &#xa0;10.1016/j.molcel.2009.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2009.06.003</ArticleId><ArticleId IdType="pmc">PMC2763548</ArticleId><ArticleId IdType="pubmed">19560422</ArticleId></ArticleIdList></Reference><Reference><Citation>He CL, Liu M, Tan ZX, Hu YJ, Zhang QY, Kuang XM, et al. Hepatitis C virus core protein-induced miR-93-5p up-regulation inhibits interferon signaling pathway by targeting IFNAR1. World J Gastroenterol (2018) 24(2):226&#x2013;36. &#xa0;10.3748/wjg.v24.i2.226</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v24.i2.226</ArticleId><ArticleId IdType="pmc">PMC5768941</ArticleId><ArticleId IdType="pubmed">29375208</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Lai C, Gu H, Zhao L, Xia M, Yang P, et al. miR-194 Inhibits Innate Antiviral Immunity by Targeting FGF2 in Influenza H1N1 Virus Infection. Front Microbiol (2017) 8:2187. &#xa0;10.3389/fmicb.2017.02187</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.02187</ArticleId><ArticleId IdType="pmc">PMC5674008</ArticleId><ArticleId IdType="pubmed">29163456</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu T, Chu Q, Cui J, Bi D. Inducible MicroRNA-3570 Feedback Inhibits the RIG-I-Dependent Innate Immune Response to Rhabdovirus in Teleost Fish by Targeting MAVS/IPS-1. J Virol (2018) 92(2):e01594&#x2013;17. &#xa0;10.1128/JVI.01594-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01594-17</ArticleId><ArticleId IdType="pmc">PMC5752954</ArticleId><ArticleId IdType="pubmed">29093090</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceolotto G, Giannella A, Albiero M, Kuppusamy M, Radu C, Simioni P, et al. miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways. Cardiovasc Res (2017) 113(13):1627&#x2013;38. &#xa0;10.1093/cvr/cvx157</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvx157</ArticleId><ArticleId IdType="pubmed">29016810</ArticleId></ArticleIdList></Reference><Reference><Citation>Su X, Qian C, Zhang Q, Hou J, Gu Y, Han Y, et al. miRNomes of haematopoietic stem cells and dendritic cells identify miR-30b as a regulator of Notch1. Nat Commun (2013) 4:2903. &#xa0;10.1038/ncomms3903</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms3903</ArticleId><ArticleId IdType="pmc">PMC3863901</ArticleId><ArticleId IdType="pubmed">24309499</ArticleId></ArticleIdList></Reference><Reference><Citation>Heikel G, Choudhury NR, Michlewski G. The role of Trim25 in development, disease and RNA metabolism. Biochem Soc Trans (2016) 44(4):1045&#x2013;50. 10.1042/BST20160077</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20160077</ArticleId><ArticleId IdType="pubmed">27528750</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparrer KM, Gack MU. Intracellular detection of viral nucleic acids. Curr Opin Microbiol (2015) 26:1&#x2013;9. 10.1016/j.mib.2015.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2015.03.001</ArticleId><ArticleId IdType="pmc">PMC5084527</ArticleId><ArticleId IdType="pubmed">25795286</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan YK, Gack MU. Viral evasion of intracellular DNA and RNA sensing. Nat Rev Microbiol (2016) 14(6):360. 10.1038/nrmicro.2016.45</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2016.45</ArticleId><ArticleId IdType="pmc">PMC5072394</ArticleId><ArticleId IdType="pubmed">27174148</ArticleId></ArticleIdList></Reference><Reference><Citation>Gack MU, Albrecht RA, Urano T, Inn K-S, Huang I-C, Carnero E, et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe (2009) 5(5):439&#x2013;49. 10.1016/j.chom.2009.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2009.04.006</ArticleId><ArticleId IdType="pmc">PMC2737813</ArticleId><ArticleId IdType="pubmed">19454348</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Vicente M, Medrano LM, Resino S, Garcia-Sastre A, Martinez I. TRIM25 in the Regulation of the Antiviral Innate Immunity. Front Immunol (2017) 8:1187. &#xa0;10.3389/fimmu.2017.01187</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01187</ArticleId><ArticleId IdType="pmc">PMC5614919</ArticleId><ArticleId IdType="pubmed">29018447</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyerson NR, Zhou L, Guo YR, Zhao C, Tao YJ, Krug RM, et al. Nuclear TRIM25 Specifically Targets Influenza Virus Ribonucleoproteins to Block the Onset of RNA Chain Elongation. Cell Host Microbe (2017) 22(5):627&#x2013;38.e627. &#xa0;10.1016/j.chom.2017.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2017.10.003</ArticleId><ArticleId IdType="pmc">PMC6309188</ArticleId><ArticleId IdType="pubmed">29107643</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Yla-Anttila P, Callegari S, Tsai MH, Delecluse HJ, Masucci MG. Herpesvirus deconjugases inhibit the IFN response by promoting TRIM25 autoubiquitination and functional inactivation of the RIG-I signalosome. PLoS Pathog (2018) 14(1):e1006852. &#xa0;10.1371/journal.ppat.1006852</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006852</ArticleId><ArticleId IdType="pmc">PMC5794190</ArticleId><ArticleId IdType="pubmed">29357390</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Li M, Song Y, Xu W. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production. Front Immunol (2018) 9:2479. &#xa0;10.3389/fimmu.2018.02479</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02479</ArticleId><ArticleId IdType="pmc">PMC6209670</ArticleId><ArticleId IdType="pubmed">30410495</ArticleId></ArticleIdList></Reference><Reference><Citation>Bookout AL, Cummins CL, Mangelsdorf DJ, Pesola JM, Kramer MF. High-throughput real-time quantitative reverse transcription PCR. Curr Protoc Mol Biol (2006) Chapter 15Unit 15.8. &#xa0;10.1002/0471142727.mb1508s73</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471142727.mb1508s73</ArticleId><ArticleId IdType="pubmed">18265376</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Wei Z, Zhou Y, Gao F, Jiang Y, Yu L, et al. Host miR-26a suppresses replication of porcine reproductive and respiratory syndrome virus by upregulating type I interferons. Virus Res (2015) 195:86&#x2013;94. &#xa0;10.1016/j.virusres.2014.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.08.012</ArticleId><ArticleId IdType="pmc">PMC7114497</ArticleId><ArticleId IdType="pubmed">25218480</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang WX, Wilfred BR, Hu Y, Stromberg AJ, Nelson PT. Anti-Argonaute RIP-Chip shows that miRNA transfections alter global patterns of mRNA recruitment to microribonucleoprotein complexes. RNA (2010) 16(2):394&#x2013;404. &#xa0;10.1261/rna.1905910</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.1905910</ArticleId><ArticleId IdType="pmc">PMC2811668</ArticleId><ArticleId IdType="pubmed">20042474</ArticleId></ArticleIdList></Reference><Reference><Citation>Corsten MF, Heggermont W, Papageorgiou AP, Deckx S, Tijsma A, Verhesen W, et al. The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis. Eur Heart J (2015) 36(42):2909&#x2013;19. &#xa0;10.1093/eurheartj/ehv321</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv321</ArticleId><ArticleId IdType="pubmed">26206211</ArticleId></ArticleIdList></Reference><Reference><Citation>Corsten MF, Papageorgiou A, Verhesen W, Carai P, Lindow M, Obad S, et al. MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis. Circ Res (2012) 111(4):415&#x2013;25. &#xa0;10.1161/CIRCRESAHA.112.267443</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.112.267443</ArticleId><ArticleId IdType="pubmed">22715471</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang D, Li M, Yu Y, Shi H, Chen R. microRNA-34a aggravates coxsackievirus B3-induced apoptosis of cardiomyocytes through the SIRT1-p53 pathway. J Med Virol (2019) 91(9):1643&#x2013;51. &#xa0;10.1002/jmv.25482</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25482</ArticleId><ArticleId IdType="pubmed">30968966</ArticleId></ArticleIdList></Reference><Reference><Citation>Gou W, Zhang Z, Yang C, Li Y. MiR-223/Pknox1 axis protects mice from CVB3-induced viral myocarditis by modulating macrophage polarization. Exp Cell Res (2018) 366(1):41&#x2013;8. &#xa0;10.1016/j.yexcr.2018.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2018.03.004</ArticleId><ArticleId IdType="pubmed">29524390</ArticleId></ArticleIdList></Reference><Reference><Citation>He F, Xiao Z, Yao H, Li S, Feng M, Wang W, et al. The protective role of microRNA-21 against coxsackievirus B3 infection through targeting the MAP2K3/P38 MAPK signaling pathway. J Transl Med (2019) 17(1):335. &#xa0;10.1186/s12967-019-2077-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-2077-y</ArticleId><ArticleId IdType="pmc">PMC6778380</ArticleId><ArticleId IdType="pubmed">31585536</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, Wang H, Du L, Wei Z, Zhang Q, Feng WH. MicroRNA-30c targets the interferon-alpha/beta receptor beta chain to promote type 2 PRRSV infection. J Gen Virol (2018) 99(12):1671&#x2013;80. &#xa0;10.1099/jgv.0.001166</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.001166</ArticleId><ArticleId IdType="pubmed">30382935</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Huang C, Yang Q, Gao L, Liu HC, Tang J, et al. MicroRNA-30c Modulates Type I IFN Responses To Facilitate Porcine Reproductive and Respiratory Syndrome Virus Infection by Targeting JAK1. J Immunol (2016) 196(5):2272&#x2013;82. &#xa0;10.4049/jimmunol.1502006</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1502006</ArticleId><ArticleId IdType="pubmed">26826240</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X, Yu S, Ren P, Sun X, Jin M. Human microRNA-30 inhibits influenza virus infection by suppressing the expression of SOCS1, SOCS3, and NEDD4. Cell Microbiol (2020) 22(5):e13150. &#xa0;10.1111/cmi.13150</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.13150</ArticleId><ArticleId IdType="pmc">PMC7162240</ArticleId><ArticleId IdType="pubmed">31876380</ArticleId></ArticleIdList></Reference><Reference><Citation>Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature (2007) 446(7138):916&#x2013;20. &#xa0;10.1038/nature05732</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05732</ArticleId><ArticleId IdType="pubmed">17392790</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>